VivoSeq
Other

Botulinum Toxin

0

Pipeline Programs↗

23

Active Trials↗

4

Companies Involved↗

Botulinum Toxin is an early-stage landscape with 0 programs across 4 companies. The most active players are AbbVie, Revance Therapeutics, Inc., Merz Pharmaceuticals GmbH.

Intelligence

Pipeline Metrics

Competitive Density

38/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

85/100

Attrition Rate

9/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

AbbVie logo

AbbVie

0 programs

PreclinicalR

Revance Therapeutics, Inc.

0 programs

PreclinicalM

Merz Pharmaceuticals GmbH

0 programs

PreclinicalP

Pacific Pharmaceuticals

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

138

clinical trials

Completed76 · 55%
Unknown status26 · 19%
Recruiting10 · 7%
Not yet recruiting8 · 6%
Terminated8 · 6%
Withdrawn5 · 4%
Other5 · 4%

Clinical Trials

Trial Activity

138 trials

Botulinum Toxin in Raynaud's Phenomenon
Recruiting·EEmory University·Phase 4·NCT05125029·36 enrolled
Peripheral TMD Pain Mechanisms and the Effect by Botulinum Toxin A
Recruiting·KKarolinska Institutet·Phase 2·NCT05720065·50 enrolled
Use of Botulinum Toxin A in Direct Eyebrow Lift Scar
Recruiting·UUniversity of Sao Paulo·Phase 2·NCT06465056·40 enrolled
Ultrasound-guided Botulinum Toxin Injection on Cricopharyngeal Muscle Dysfunction
Recruiting·—·N/A·NCT06271395·30 enrolled
Botulinum Toxin Injection in Reducing Scar Following Cheilorrhaphy.
Recruiting·MMansoura University·N/A·NCT07137234·32 enrolled
Effect of Botulinum Toxin Injection Into Upper Esophageal Sphincter in Patients With Medullary Infarction
Recruiting·TThe First Affiliated Hospital of Zhengzhou University·N/A·NCT06196606·20 enrolled
Mechanisms of Action on Rectal Motricity of Intrarectal Botulinum Toxin Injections
Recruiting·UUniversity Hospital, Rouen·Phase 3·NCT05998187·21 enrolled
Effect of Blood Flow by Botulinum Toxin Injection for Severe Peripheral Artery Occlusive Disease
Recruiting·YYonsei University·Phase 4·NCT06878482·15 enrolled
Effectiveness and Safety of Early Intramuscular Botulinum Toxin Injections to Prevent Shoulder Deformity in Babies With Obstetrical Brachial Plexus Palsy
Recruiting·UUniversity Hospital, Brest·Phase 3·NCT03198702·62 enrolled
Intrapapillary Botulinum Toxin Injection for PREvention of Post-surgical PAncREactic Fistula
Recruiting·AAssistance Publique - Hôpitaux de Paris·N/A·NCT04220931·460 enrolled
A Comparative Study on the Impact of Trigger Points Injection of Platelet Rich Plasma Versus Botulinum Toxin on the Relief of Jaw Muscles Myofascial Pain
Active, not recruiting·—·Phase 2/3·NCT06814535·60 enrolled
Botulinum Toxin Injection in the UES for R-CPD
Active, not recruiting·AAZ Delta·Phase 4·NCT06356025·50 enrolled
Rectocele Repair with or Without Internal Sphincter Botulinum Toxin Injection: a Prospective Randomized Trial
Active, not recruiting·MMansoura University·Phase 4·NCT06804993·60 enrolled
Efficacy of One or Two Botulinum Toxin Injections in the Treatment of Chronic Lateral Epicondylalgia: a Retrospective Study (EPITOX)
Active, not recruiting·UUniversity Hospital, Brest·N/A·NCT06765694·80 enrolled
Clinical Effects of Incobotulinum Toxin vs Corticosteroid in Plantar Fascitis
Active, not recruiting·IInstituto Mexicano del Seguro Social·Phase 1·NCT06788158·20 enrolled
Page 1 of 10

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)